In 2016 the FDA Guidance “Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products” permitted MSM to donate if they have not had sex with a man in the last 12 months (formerly not permitted if “since 1977”). There has now been enough time to evaluate the impact of this change. Currently many countries with 12 month deferrals have either moved to policies that are less restrictive (shorter time-deferrals or permitting some low-risk MSM to donate without a time deferral) or are considering doing so. This session will delve into the evidence considered when making these policy decisions, and evaluate the safety and sufficiency of the blood supply post-implementation. In this session the AABB Donor History Task Force and the International Society for Blood Transfusion Transfusion-Transmitted Infectious Diseases Working Party will present the following:
A description of the range of policies that address blood donation for MSM including time-deferrals, plasma quarantine strategies and alternative risk questions. Examples of policies in a range of different countries will be presented.
With 2 years since implementing the 12 month deferral in the USA, data and risk assessment pre-implementation and data evaluating the safety impact post-implementation will be presented.
With almost 2 years since implementing a 3 month deferral in the United Kingdom, data and risk assessment pre-implementation will be described as well the post-implementation evaluation.
Data considered when evaluating a proposal to decrease deferral from 12 months to 3 months in Canada will be described. Current research relating to assessment of other potential policies that could permit some low risk MSM to donate without time deferral in Canada will be discussed.
Describe a range of policies that address blood donation for Men Who Have Sex with Men (MSM) including time-deferrals, plasma quarantine strategies and alternative risk questions.
Differentiate MSM donor policies in the US, the UK and Canada.
Explain research approaches intended to provide data to inform further changes to MSM donor policy.